Global Regenerative Medicine Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024

Industry : Healthcare Date : March 18th, 2019
Tutorials Get 15% Discount on First Report

Global regenerative medicine market is expected to reach USD 79.8 billion by 2024, at a CAGR of 20.5% from 2018 to 2024. Factors driving the growth of the market are; increasing prevalence of degenerative and chronic diseases, technological advancements in nanotechnology, bioengineering and stem cell therapy, and increasing geriatric population across the globe. Moreover, limited number of organs available through donation and increasing investment by governments and private players is further augmenting the growth of the market. The years used for the assessment are as follows;

Historical year:2014, 2015, and 2016

Base year:2017

Forecast period:2018 – 2024

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

  • Obtaining historical data of the market based on news, articles, publications, government websites, annual reports, press releases, white papers, surveys, investor presentation of companies, and other secondary sources
  • Interacting with key opinion leaders of the market and developing data points based on interaction with them
  • Study of past trends in the market and their year on year Impact on the market size and share
  • Analyzing the collected data points
  • Bridging the data points to calculate the total global regenerative medicine market and its various segments
  • Anticipating potential risks
  • Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global regenerative medicine market
  • Finalizing the overall size and share of the global regenerative medicine market

OBJECTIVES:

  • To analyze market trends, opportunities, drivers, and restraints associated with the global regenerative medicine market
  • To study market response with respect to the mergers and acquisitions in the industry
  • To profile key companies operating in the regenerative medicine market and provide their competitive landscape

MARKET SCOPE

The research scope for global regenerative medicine market is as follows:

By Technology

  • Cell Therapy
  • Small Molecules and Biologics
  • Tissue Engineering
  • Gene Therapy

By Application

  • Dermatology
  • Dental
  • Orthopedic
  • Central Nervous System Diseases
  • Cardiovascular
  • Autoimmune Disorders
  • Muscle Regeneration
  • Ocular Diseases
  • Oncology

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Central & South America
  • Middle East and Africa

Regenerative medicine has been recognized across the globe as a developing research field that offers the potential to revolutionize patients care. The strong demand of regenerative medicine products has been driven by increasing degenerative and chronic diseases, which place cost pressures on healthcare providers, and technological advancements in nanotechnology, bioengineering and stem cell therapy.

Geographically, the global Regenerative Medicine market is segmented into North America, Europe, Asia-Pacific, Central & South America, and Middle East and Africa. North America held the major share of the global market owing to the technological advancements in tissue engineering, and increasing investments in research and development activities. Moreover, increasing incidence of degenerative diseases and presence of advanced healthcare infrastructure is further propelling the industry growth in the region.  The growth of the market in Europe is attributed to increasing aging population, and growing number of chronic diseases. Asia-Pacific is expected to witness the highest CAGR during 2018-2024, owing to increasing prevalence of chronic diseases, and rapidly growing healthcare sector. Moreover, growing development in stem cell therapy and tissue engineering are further propelling the market growth in the region. Furthermore, favorable government policies and increasing awareness among healthcare professionals are also boosting the industry growth in the region.

Some of the key companies operating in the market include Osiris Therapeutics, Inc., Novartis AG, TxCell, Inc., Cellectis, Inc., NuVasive, Inc., Integra LifeSciences Corporation, MiMedx Group, Inc., Cellular Biomedicine Group, Inc., Spark Therapeutics, Inc., and Vericel Corporation among others.global regenerative medicine market

TABLE OF CONTENTS

CHAPTER 1. Market Scope and Methodology

1.1. Research methodology

1.2. Research scope & assumptions

1.3. List of data sources

CHAPTER 2. Executive Summary

2.1. Regenerative Medicine- Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market definition

3.2. Market segmentation

3.3. Key findings of the global regenerative medicine market

3.4. Value chain analysis

3.5. Market opportunities & trends

3.5.1. Technological advancements in nanotechnology, bioengineering, and stem cell therapy

3.5.2. Increasing number of mergers & acquisitions in regenerative medicine

3.6. Market driver analysis

3.6.1. Increasing prevalence of degenerative and chronic diseases

3.6.2. Increasing geriatric population across the globe

3.6.3. Limited number of organs available through donation

3.6.4. Increasing investments by governments and private players

3.7. Market restraint analysis

3.7.1. Stringent government regulations

CHAPTER 4. Competitive Outlook

4.1. Competitive Aanalysis

4.1.1. Industry Analysis-Porters five forces analysis

4.1.2. Company Share Analysis

4.2. Competitive factors

CHAPTER 5. Global Regenerative Medicine Market Size and Forecast (2014 – 2024)

5.1. Global Regenerative Medicine Market, By Technology

5.1.1. Cell Therapy

5.1.2. Small Molecules and Biologics

5.1.3. Tissue Engineering

5.1.4. Gene Therapy

5.2. Global Regenerative Medicine Market, By Application

5.2.1. Dermatology

5.2.2. Dental

5.2.3. Orthopedic

5.2.4. Central Nervous System Diseases

5.2.5. Cardiovascular

5.2.6. Autoimmune Disorders

5.2.7. Muscle Regeneration

5.2.8. Ocular Diseases

5.2.9. Oncology

5.3. Global Regenerative Medicine Market, By Region

5.3.1. North America

5.3.2. Europe

5.3.3. Asia-Pacific

5.3.4. Central and South Africa

5.3.5. Middle East and Africa

CHAPTER 6. Global Regenerative Medicine Market, By Geography

6.1. North America Regenerative Medicine Market

6.1.1. North America Regenerative Medicine Market, By Technology (USD Billion)

6.1.2. North America Regenerative Medicine Market, By Application (USD Billion)

6.1.3. North America Regenerative Medicine Market, By Country

   6.1.3.1. U.S.

   6.1.3.2. Canada

   6.1.3.3. Mexico

6.2. Europe Regenerative Medicine Market

6.2.1. Europe Regenerative Medicine Market, By Technology (USD Billion)

6.2.2. Europe Regenerative Medicine Market, By Application (USD Billion)

6.2.3. Europe Regenerative Medicine Market, By Country

   6.2.3.1. Germany

   6.2.3.2. France

   6.2.3.3. U.K.

   6.2.3.4. Italy

   6.2.3.5. Spain

   6.2.3.6. Rest of Europe

6.3. Asia-Pacific Regenerative Medicine Market

6.3.1. Asia-Pacific Regenerative Medicine Market, By Technology (USD Billion)

6.3.2. Asia-Pacific Regenerative Medicine Market, By Application (USD Billion)

6.3.3. Asia-Pacific Regenerative Medicine Market, By Country

   6.3.3.1. China

   6.3.3.2. Australia

   6.3.3.3. Japan

   6.3.3.4. South Korea

   6.3.3.5. India

   6.3.3.6. Rest of Asia-Pacific

6.4. Cenral and South Africa Regenerative Medicine Market

6.4.1. Cenral and South Africa Regenerative Medicine Market, By Technology (USD Billion)

6.4.2. Cenral and South Africa Regenerative Medicine Market, By Application (USD Billion)

6.4.3. Central and South Africa Regenerative Medicine Market, By Country

   6.4.3.1. Brazil

   6.4.3.2. Rest of Central and South America

6.5. Middle East and Africa Regenerative Medicine Market

6.5.1. Middle East and Africa Regenerative Medicine Market, By Technology (USD Billion)

6.5.2. Middle East and Africa Regenerative Medicine Market, By Application (USD Billion)

6.5.3. Middle East and Africa Regenerative Medicine Market, By Country

   6.5.3.1. South Africa

   6.5.3.2. Saudi Arabia

   6.5.3.3. Rest of Middle East and Africa

CHAPTER 7. Key Players and Strategic Developments

7.1. Osiris Therapeutics, Inc.

7.1.1. Business Overview

7.1.2. Product and Service Offering

7.1.3. Financial Overview

7.1.4. Strategic Developments

7.2. Novartis AG

7.2.1. Business Overview

7.2.2. Product and Service Offering

7.2.3. Financial Overview

7.2.4. Strategic Developments

7.3. TxCell, Inc.

7.3.1. Business Overview

7.3.2. Product and Service Offering

7.3.3. Financial Overview

7.3.4. Strategic Developments

7.4. Cellectis, Inc.

7.4.1. Business Overview

7.4.2. Product and Service Offering

7.4.3. Financial Overview

7.4.4. Strategic Developments

7.5. NuVasive, Inc.

7.5.1. Business Overview

7.5.2. Product and Service Offering

7.5.3. Financial Overview

7.5.4. Strategic Developments

7.6. Integra LifeSciences Corporation

7.6.1. Business Overview

7.6.2. Product and Service Offering

7.6.3. Financial Overview

7.6.4. Strategic Developments

7.7. MiMedx Group, Inc.

7.7.1. Business Overview

7.7.2. Product and Service Offering

7.7.3. Financial Overview

7.7.4. Strategic Developments

7.8. Cellular Biomedicine Group, Inc.

7.8.1. Business Overview

7.8.2. Product and Service Offering

7.8.3. Financial Overview

7.8.4. Strategic Developments

7.9. Vericel Corporation

7.9.1. Business Overview

7.9.2. Product and Service Offering

7.9.3. Financial Overview

7.9.4. Strategic Developments

7.10. Spark Therapeutics, Inc.

7.10.1. Business Overview

7.10.2. Product and Service Offering

7.10.3. Financial Overview

7.10.4. Strategic Developments

7.11. Abbreviation

Global Regenerative Medicine Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024